Florida
How Bruesewitz v. Wyeth LLC applies in Florida: state-specific rules, key cases, and bar exam notes for Products Liability (Preemption).
Florida follows a strict products liability doctrine which allows for claims against manufacturers for defects. However, in line with federal law and the principles established in Bruesewitz, Florida recognizes preemption under the National Childhood Vaccine Injury Act, which limits liability for vaccine-related injuries.
In Florida, a manufacturer of a vaccine that is approved by the FDA and is in compliance with federal regulations may be protected from liability claims that relate to design defects.
The court held that if a product is determined to be extensively regulated by federal law, state claims regarding design defects may be preempted.
This case reinforced that preemption applies when federal statutes provide comprehensive regulatory schemes that conflict with state liability theories.
In this case, the court affirmed that compliance with federal regulations is key to establishing a defense against state law claims related to pharmaceuticals.
Florida's approach mirrors the federal standard established in Bruesewitz by limiting liability for federally approved vaccines. Both systems recognize federal supremacy and provide similar defenses against design defect claims when statutory compliance is evident.
Understanding the preemptive effect of the National Vaccine Injury Compensation Program is critical; it may appear in exam questions regarding products liability involving vaccines.